Hydrochloric Acid → 3-(4-piperidinyl)-5-(3-thienyl)-1H-indole-7-carboxamide
反応式
N1CCC(C2C3C(=C(C(N)=O)C=C(C4SC=CC=4)C=3)NC=2)CC1.[NH2:24][C:25]([C:27]1[CH:28]=[C:29]([C:49]2[CH:53]=[CH:52][S:51][CH:50]=2)[CH:30]=[C:31]2[C:35]=1[NH:34][CH:33]=[C:32]2[CH:36]1[CH2:41][CH2:40][N:39](C(OC(C)(C)C)=O)[CH2:38][CH2:37]1)=[O:26].Cl>CO>[NH:39]1[CH2:40][CH2:41][CH:36]([C:32]2[C:31]3[C:35](=[C:27]([C:25]([NH2:24])=[O:26])[CH:28]=[C:29]([C:49]4[CH:53]=[CH:52][S:51][CH:50]=4)[CH:30]=3)[NH:34][CH:33]=2)[CH2:37][CH2:38]1参加物
5
反応物 3
生成物 1
試薬・触媒・溶媒 1
実験手順
The title compound was prepared according to the general procedure for intermediate 17. Thus, 1,1-dimethylethyl 4-[7-(aminocarbonyl)-5-(3-thienyl)-1H-indol-3-yl]-1-piperidinecarboxylate (460 mg, 1.08 mmol) and HCl (4.0M in dioxane, 10 mL) in MeOH (5 mL) was reacted to form the desired product without further purification (260 mg, 74%).
後処理
- customThe title compound was prepared
出典と根拠
- ORDレコード
- ord-c034074e77884819bfd900f4079b66d1
- 出典データセット
- uspto-grants-2010_12
- 特許番号
- US07858796B2
反応ノート
読み込み中…